Kingston Mills is Professor of Experimental Immunology, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute (TBSI), Trinity College Dublin (TCD). He is Head of the Immunology, Inflammation and Infection research theme at TCD and Head of the Centre for the Study of Immunology in TBSI. He trained at as a Postdoctoral Fellow at University College London and the MRC National Institute for Medical Research, Mill Hill, London (now the Crick Institute), before joining the Scientific Staff of National Institute for Biological Standards and Control (NIBSC), Herts, UK. He was appointed to a Personal Chair at TCD in 2001 and was Head of the School of Biochemistry and Immunology from 2008-2011. He is a co-founder of University spin-out companies Opsona Therapeutics and TriMod Therapeutics. His research focuses on the role of the immune system, in particular T cell subtypes, in immunity to infection, cancer and autoimmunity.